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Tuesday, February 5, 2013 441afor ATP (ATeam), respectively.Results:Overexpressed RyR1 was partially
localized in mitochondria, but the another RyR isoform RyR2 did not show
any co-localization with mitochondria. Over-expression of RyR1 but not
MCU and RyR2 showed the mitochondrial fragmentation. Fragmented mito-
chondria showed higher [Ca2þ]m at peak and sustained Ca
2þ transients com-
pared to elongated mitochondria. RyR1 overexpressed cells had higher
[ATP]m at the basal condition and showed more ATP production in response
to [Ca2þ]c elevation compared to non-transfected cells.Conclusion:Mitochon-
drial RyR1 strongly modulates mitochondrial morphology, Ca2þ influx and
Ca2þ-induced ATP production in cardiac cells.
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Introduction: Intracellular sodium (Naþi) overload of cardiomyocytes is asso-
ciated with abnormal calcium (Ca2þi) homeostasis and cell dysfunction. We
hypothesized that the impaired Ca2þ handling is triggered by reactive oxygen
species (ROS) -activated Ca2þ/Calmodulin-dependent protein kinase II
(CaMKII) which in turn on modulation of ryanodine receptor (RyR) activity,
leading to Ca2þ leak from the sarcoplasmic reticulum (SR).
Methods: We used confocal fluorescent imaging of intact and membrane-
permeabilized rabbit ventricular cardiomyocytes to study Naþi overload,
Ca2þi transients, and ROS production. Na
þ
i overload in intact cardiomyocytes
was induced by anemone toxin-II (ATX-II), a late Naþ current (INaL) enhancer.
CaMKII oxidation and phosphorylation were measured using Western Blot
analysis.
Results: Rabbit ventricular myocytes treated with ATX-II (5 nM) exhibited
Naþi overload, aberrant Ca
2þ
i transients, and enhanced ROS production, ac-
companied by CaMKII oxidation and phosphorylation. CaMKII activation
was reduced by the INaL inhibitor ranolazine (10 mM), by antioxidants
(5 mM DDT or 10 mM Q10co), or by the CaMKII inhibitor KN93 (10 mM).
These findings indicate a pathogenic cascade of events from Naþi overload
to ROS production and to CaMKII activation. To determine how ROS and
CaMKII contribute to the Ca2þi mishandling caused by Na
þ
i overload, we stud-
ied spontaneous Ca2þ waves in membrane-permeabilized myocytes. Superfu-
sion with high Naþ solutions elevated diastolic Ca2þi and accelerated Ca
2þ
waves frequency. These effects indicated Ca2þ leak through RyRs. These
Ca2þ changes were dependent from ROS and CaMKII inhibition.
Conclusions: The data show that Naþi overload causes Ca
2þ
i mishandling
through increased ROS production and CaMKII activation. Naþi overload en-
hances ROS production, which activates CaMKII, leading to the phosphoryla-
tion of RyRs, resulting in SR Ca2þ leak and increase in diastolic Ca2þ.
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RyR2-mediated intracellular Ca2þ release is pivotal in maintaining the rhyth-
mic contraction of cardiac myocytes. The precise mechanism by which binding
of cytosolic Ca2þ triggers gating is unknown. Functional studies of single
RyR2s in lipid bilayers provide insights into gating behaviour as detailed struc-
tural information regarding the nature of the Ca2þ-dependent gate or Ca2þ
binding site(s) is as yet unavailable.
This study aims to uncover the properties of the Ca2þ-controlled ‘gate’ by ex-
amining changes in single channel gating in the virtual absence of Ca2þ. To vi-
sualize these changes, ryanodine was employed to keep the channel open in
a subconductance state in the presence and absence of Ca2þ, while Kþ was
used as the permeant ion for better resolution of single channel currents. On re-
ducing the Ca2þ from contaminant levels to nominally zero on both cytosolic
and luminal sides of the ryanodine-modified hRyR2 (using 3.5mM EGTA),
a significant decrease in channel Po is seen at positive (current direction:
cytosolic-luminal) holding potentials but not in the physiological direction of
current flow (0.9950.002 to 0.7550.05 at þ40mV (p<0.0005) and 0.99 to
0.9850.009 at 40mV; n=9). Analysis of dwell times demonstrates that
Po decreases by increasing the frequency of closings (~170 fold increase at
þ40mV, ~8-fold at 40mV). Further examination of the voltage sensitivity
of the modified channel reveals a sharp dependence of activity on potential.
High cytosolic Ba2þ had a direct inhibitory effect on the gating kinetics inducedby the removal of Ca2þ. This study demonstrates that ryanodine modifies RyR2
by acting on a Ca2þ-controlled gate and gating of the modified channel is
voltage-sensitive. HMM-based modeling of this data provides further insights
into this fundamental process of Ca2þ-induced channel opening. This study is
supported by the BHF.
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The human cardiac ryanodine receptor (hRyR2) undergoes luminal regulation
by accessory proteins including junctin (JUN) and calsequestrin (CSQ2). Fur-
thermore, it has been suggested that defective luminal Ca2þ sensing by RyR2
is a candidate mechanism in the pathogenesis of catecholaminergic polymor-
phic ventricular tachycardia - an arrhythmogenic disorder caused by mutation
of RyR2 or CSQ2. As such, we evaluated the effects of CSQ2 and JUN on
mutant channel behaviour. [3H]-ryanodine binding was used to evaluate the
cytosolic Ca2þ activation of wild-type (WT) or novel CPVT mutant
(A4556T, positioned close to a JUN binding site) which were recombinantly
(co)expressed in the presence/absence of CSQ2 and/or JUN in HEK293 cells,
while store overload-induced Ca2þ-release (SOICR) events were monitored to
ascertain luminal Ca2þ effects. Co-immunoprecipitation experiments demon-
strated that WT and mutant proteins showed equal association with both lumi-
nal accessory proteins. Co-expression of WT RyR2 with CSQ2 alone did not
affect the amplitude, frequency or rate of release of SOICR events while pre-
liminary experiments show that co-expression with JUN (alone and in combi-
nation with CSQ2) decreased the amplitude and increased the frequency of
events, in line with observations that JUN both inhibits and activates RyR2
depending on SR Ca2þ levels. Co-expression of both accessory proteins sig-
nificantly decreased the rate of release. Activation of WT RyR2 by cytosolic
Ca2þ was not affected by the presence of either/both accessory proteins.
A4556T showed enhanced activation in response to cytosolic Ca2þ that de-
creased to WT levels (at low Ca2þ concentrations only) in the presence of
both JUN and CSQ2. This indicates that regulation by JUN and CSQ2 to
some extent attenuates mutant dysfunction and will be further investigated
by monitoring Ca2þ release events and single channel analysis. This work
is supported by the BHF.
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Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited
arrhythmogenic disease. Naturally occurring mutations in the cardiac ryano-
dine receptor (RyR2) and calsequestrin (CASQ2) have been linked to CPVT.
The sarcoplasmic reticulum calcium content and the sensitivity of RyR2 to lu-
minal calcium are two important factors determining the propensity for store
overload induced spontaneous calcium release, also known as store-overload
induced calcium release (SOICR), and SOICR-evoked VTs. We recently found
that residue E4872 of RyR2 is critical for luminal calcium sensing. In the pres-
ent study, we determined whether the RyR2-E4872Q mutation is capable of
rescuing the VT phenotype of the CASQ2 null mice. We bred E4872Qþ/-
mice with CASQ2 null mice to produce CASQ2-/- or CASQ2þ/- mice with
or without the RyR2-E4872Q mutation. CASQ2-/- and CASQ2þ/- mice with-
out the RyR2-E4872Q mutation showed long lasting stress-induced VTs,
whereas CASQ2-/- / E4872Qþ/- and CASQ2þ/- / E4872Q þ/- displayed little
or no VTs. Thus, the RyR2-E4872Q mutation nearly completely protected the
CASQ2 null mice from CPVT. We next studied the impact of the RyR2-
E4872Q mutation on calcium handling in intact hearts using linescan confocal
calcium imaging. The properties of calcium transients did not differ signifi-
cantly between CASQ2-/- hearts with or without the RyR2-E4872Q mutation
at resting conditions. However, upon elevation of external calcium from
2mM to 7mM or adding 100nM isoproterenol, frequent spontaneous calcium
waves occurred in CASQ2-/- hearts without the RyR2-E4872Q mutation, but
not in CASQ2-/- / E4872Qþ/- hearts. These observations indicate that targeting
the luminal calcium sensor of RyR2 represents a new therapeutic strategy for
suppressing CPVT and other calcium mediated cardiac arrhythmias. (Support
by NIH R01HL75210)
